Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7407 p3-8
1 July 2006

This section
Reprint   Photocopy

PDF 150K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events   Conferences

Pages: 3   4   5   6   7   8 

3 New hypertension treatment recommendations Beta-blockers are no longer recommended as routine initial therapy for hypertension in England and Wales, say the National Institute for Health and Clinical Excellence and the British Hypertension Society in an updated guideline
PJ 2006;277:3
Full Text

3 NICE drug evaluations have not been discredited, says Prime Minister Prime Minister Tony Blair has defended the National Institute for Health and Clinical Excellence as a way of evaluating drugs for use by the NHS
PJ 2006;277:3
Full Text

3 Scottish contract and minor ailment service start on 1 July This weekend sees the start of Scotland’s new community pharmacy contract. From 1 July, pharmacists can offer consultations through the minor ailment service
PJ 2006;277:3
Full Text


4 Examination introduced for registering in Australia UK qualified pharmacists who want to work in Australia will soon have to take a competency examination before they can register, the Council of Pharmacy Registering Authorities (COPRA) and the Australian Pharmacy Examining Council have announced
PJ 2006;277:4
Full Text

4 Science funding restricts pharmacy education, warns the Society Continued funding of pharmacy degrees as science, rather than clinical, degrees is likely to create a pinch point in pharmacy education, the House of Commons’ Health Select Committee has been told
PJ 2006;277:4
Full Text

4 Scottish NHS drugs inquiry Prescribing and licensing of drugs in NHS Scotland was the topic of an inquiry by the Scottish Parliament’s health committee
PJ 2006;277:4
Full Text

4 Pharmacists in the Irish Republic denied the right to prescribe Pharmacists in the Irish Republic have been refused the right to prescribe, even for minor ailments, despite claims that it would reduce delays for patients and ease pressure on GPs and accident and emergency departments in hospitals
PJ 2006;277:4
Full Text


5 NPA wants registration/membership link broken Membership of the Royal Pharmaceutical Society and registration as a pharmacist should cease to be linked, the National Pharmacy Association has said
PJ 2006;277:5
Full Text

5 S60 Order “a wasted opportunity” to ensure public safety, says PDA Plans for the future regulation of pharmacy are a wasted opportunity to ensure the enhanced safety of the public, the Pharmacists’ Defence Association has told the Department of Health
PJ 2006;277:5
Full Text

5 Pharmacy voice joins White Paper working group on ways to deliver care outside hospitals The Royal Pharmaceutical Society has been invited to be part of a Government working group charged with demonstrating how health care can be provided closer to home
PJ 2006;277:5
Full Text


6 TNF inhibitor infection risk coupled with lower CV risk Tumour necrosis factor (TNF) inhibitors increase patients’ risk of being admitted to hospital for infection, but appear to reduce their cardiovascular risk, two studies presented at the Annual European Congress of Rheumatology in Amsterdam last week suggest
PJ 2006;277:6
Full Text

6 Rituximab limits joint damage Rituximab plus methotrexate is associated with significant inhibition of joint structural damage in rheumatoid arthritis patients with inadequate response to one or more tumour necrosis factor inhibitors, according to data presented at the Annual European Congress of Rheumatology in Amsterdam
PJ 2006;277:6
Full Text

6 Heart attack data released How the NHS manages heart attacks has been summarised in a new report by the Myocardial Infarction National Audit Project
PJ 2006;277:6
Full Text

6 Industry self-regulation "does not work" Self-regulation of marketing activities by the pharmaceutical industry does not work and the industry demonstrates little corporate social responsibility (CSR), according to an international association of consumer groups
PJ 2006;277:6
Full Text

6 Insulin use in type 2 diabetes linked with hypertension Patients with type 2 diabetes mellitus who take insulin may be at a higher risk of developing hypertension than those who do not, a recent study has shown
PJ 2006;277:6
Full Text


7 Lung disease is latest Government priority for NSF Management of patients with chronic obstructive pulmonary disease (COPD) is set to come under scrutiny following the announcement that a new national service framework is to be developed
PJ 2006;277:7
Full Text

7 NSF update issued for paediatric renal care National service frameworks (NSFs) for renal services and children’s services have been brought together in a new document published by the Department of Health
PJ 2006;277:7
Full Text

7 Continue to use caution when prescribing naproxen Naproxen should continue to be prescribed with the same caution as for other non-steroidal anti-inflammatory drugs for patients with cardiovascular risk factors or disease, a MeReC Rapid Review concludes
PJ 2006;277:7
Full Text

7 NICE issues recommendations for management of Parkinson’s disease and prostate cancer People with Parkinson’s disease admitted to hospital or to care homes should receive their medicines at appropriate times, which may mean allowing self-medication, according to a guideline published by the National Institute for Health and Clinical Excellence
PJ 2006;277:7
Full Text


8 Rimonabant launched for the obese and overweight The first drug in a new class of anti-obesity medicines has been launched this week by sanofi aventis
PJ 2006;277:8
Full Text

8 Accessible services will be key to helping smokers quit in wake of English smoking ban Easily accessible and flexible smoking cessation services will be essential if smokers are to be motivated to quit in the wake of the smoking ban in bars and public houses in England, which is due to come into effect in October 2007, according to Robert West, of the Cancer Research UK Health Behaviour Unit at University College London
PJ 2006;277:8
Full Text

8 Smoking cessation therapies need to be used in new ways Smoking cessation medicines such as nicotine-replacement therapy and rimonabant (which was launched this week as a treatment for obesity, see above) may have to be used in new ways to help prompt smokers to quit
PJ 2006;277:8
Full Text

8 Scottish smoking ban has 99 pc adherence Scotland’s smoking ban is being adhered to, according to published figures
PJ 2006;277:8
Full Text

8 Use minimum treatment for childhood fever Parents should be advised to use the minimum medication necessary to treat fever in their children because of the lack of evidence to support one pharmacological regimen over another
PJ 2006;277:8
Full Text

Back to Top


©The Pharmaceutical Journal